💨 Abstract

A new veterinary sedative, medetomidine, is causing a crisis in U.S. cities due to severe withdrawal symptoms. Often mixed with fentanyl, it leads to life-threatening conditions like extreme blood pressure fluctuations, seizures, and potential brain damage. Hospitals, particularly in Philadelphia, are overwhelmed. The DEA notes its rise since 2021, linked to drug trafficking changes. Similar issues arose with xylazine in the UK and southern U.S.,

Courtesy: Sarah Hooper